ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.92
-0.01 (-0.52%)
At close: Aug 18, 2025, 10:40 AM

ESSA Pharma Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-31.11M -28.54M -27.67M -27.73M -25.8M -26.58M -27.42M -28.95M -32.75M -35.1M -37.34M -37.26M -39.37M -36.81M -32.78M -28.96M -25.36M
Depreciation & Amortization
406.00 n/a 88.33K 96.11K 111.05K 118.49K 121.79K 121.79K 121.79K 121.79K 120.14K 115.19K 112.33K 109.46K 94.52K 101.17K 110.32K
Stock-Based Compensation
8.44M 6.54M 5.38M 3.94M 4.25M 5.01M 6.1M 6.53M 6.95M 7.89M 8.78M 9.97M 10.77M 9.48M 7.83M 6.55M 7.47M
Other Working Capital
197.35K -385.76K -427.8K 1.87M 537.37K 2.47M -719.5K -1.59M -469.85K -471.34K 518.14K -135.24K -347.17K -721.15K 364.31K 284.94K -779.44K
Other Non-Cash Items
1.18M 1.04M 361.57K 2.34M 98.36K -271.98K -896.13K -2.56M -1.7M -954.86K -411.62K -224.64K -66.55K -35.29K -314.12K -98.42K 4.74K
Deferred Income Tax
n/a -204.07K -392.37K -596.58K -596.58K -392.5K -204.21K n/a n/a 124.08K -479.58K -1.05M 92.23K -107.02K 537.58K 1.14M 1.61K
Change in Working Capital
223.21K -414.08K -478.62K 1.66M 370.7K 2.34M -841.13K -1.6M -507K -780.01K 1.1M 342.58K 1.17M 1.95M 2.17M 2.03M 205.02K
Operating Cash Flow
-22.47M -22.78M -23.91M -21.49M -21.57M -19.78M -23.15M -26.47M -27.88M -28.7M -28.23M -28.11M -27.29M -25.42M -22.46M -19.24M -17.57M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
9.61M -39.35M -134.78M -209.3M -335.71M -365.2M -356.36M -369.51M -371.48M -296.01M -196.11M -104.98M -71.01M -55.99M -57.84M -55.83M n/a
Sales Maturities Of Investments
70.37M 131.49M 205.63M 277.66M 341.91M 361.68M 349.42M 353.29M 327.93M 242.96M 147.87M 68.48M 25.6M 21.58M 22.29M 20.3M n/a
Other Investing Acitivies
62.51M 62.52M 62.52M 62.51M -612.32K -2.74K 702.55K 692.94K -25.32M -36.93M -37.64M -37.64M -46.01M -35.01M -56.75M -56.74M -21.74M
Investing Cash Flow
79.98M 92.14M 70.85M 68.36M 5.58M -3.53M -6.23M -15.51M -42.22M -52.35M -48.25M -36.5M -44.88M -33.88M -56.75M -56.74M -21.74M
Debt Repayment
n/a n/a -32.07K -67.59K -102.23K -136.87K -139.44K -138.56K -136.29K -134.02K -130.03K -104.45K -102.37K -100.28K -787.92K -809.15K -808.27K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
81.04K 277.69K 236.44K 210.87K 215.08K 68.71K 56K 95.56K 311.07K 392.46K 430.73K 589.4K 142.04M 142.09M 188.82M 188.5M 46.86M
Financial Cash Flow
733.06K 929.72K 856.4K 795.3K 112.85K -68.16K -89.15K -48.7K 169.08K 252.74K 300.7K 484.95K 141.94M 141.99M 188.03M 187.7M 45.96M
Net Cash Flow
57.97M 70.01M 47.52M 47.38M -15.88M -23.37M -29.4M -41.94M -69.84M -80.75M -77.33M -65.33M 68.57M 81.5M 108.71M 111.65M 6.55M
Free Cash Flow
-22.47M -22.78M -23.91M -21.49M -21.57M -19.78M -23.15M -26.47M -27.88M -28.7M -28.23M -28.11M -27.29M -25.42M -22.46M -19.24M -17.57M